Page last updated: 2024-11-04

sulfasalazine and Skin Neoplasms

sulfasalazine has been researched along with Skin Neoplasms in 2 studies

Sulfasalazine: A drug that is used in the management of inflammatory bowel diseases. Its activity is generally considered to lie in its metabolic breakdown product, 5-aminosalicylic acid (see MESALAMINE) released in the colon. (From Martindale, The Extra Pharmacopoeia, 30th ed, p907)
sulfasalazine : An azobenzene consisting of diphenyldiazene having a carboxy substituent at the 4-position, a hydroxy substituent at the 3-position and a 2-pyridylaminosulphonyl substituent at the 4'-position.

Skin Neoplasms: Tumors or cancer of the SKIN.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Xu, J1
Weng, Z1
Arumugam, A1
Tang, X1
Chaudhary, SC1
Li, C1
Christiano, AM1
Elmets, CA1
Bickers, DR1
Athar, M1
Beyazit, Y1
Caner, S1
Kurt, M1
Kekilli, M1
Aydog, G1
Ibis, M1

Other Studies

2 other studies available for sulfasalazine and Skin Neoplasms

ArticleYear
Hair follicle disruption facilitates pathogenesis to UVB-induced cutaneous inflammation and basal cell carcinoma development in Ptch(+/-) mice.
    The American journal of pathology, 2014, Volume: 184, Issue:5

    Topics: Animals; Apoptosis; Biomarkers, Tumor; Carcinogenesis; Carcinoma, Basal Cell; Cell Proliferation; Fe

2014
Dermatofibroma in a patient with Crohn's disease: a novel clinical manifestation.
    Journal of Crohn's & colitis, 2010, Volume: 4, Issue:4

    Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Crohn Disease; Drug Therapy, Combination; Female; Gl

2010